tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AUPH Stock Latest News

Biotech Sector: M&A Fuels Renewed Excitement
Market NewsBiotech Sector: M&A Fuels Renewed Excitement
1d ago
NVS
XBI
Aurinia’s LUPKYNIS Wins FDA Label Update
PremiumCompany Announcements
Aurinia’s LUPKYNIS Wins FDA Label Update
1d ago
AUPH
Aurinia Pharmaceuticals: FDA approves updated LUPKYNIS label
PremiumThe Fly
Aurinia Pharmaceuticals: FDA approves updated LUPKYNIS label
1d ago
AUPH
Aurinia Pharmaceuticals to Present at Investor Conference
PremiumCompany Announcements
Aurinia Pharmaceuticals to Present at Investor Conference
15d ago
AUPH
Aurinia Pharmaceuticals Announces Q1 Results Date
PremiumCompany Announcements
Aurinia Pharmaceuticals Announces Q1 Results Date
16d ago
AUPH
Aurinia Pharma to Connect at Healthcare Investor Event
PremiumCompany AnnouncementsAurinia Pharma to Connect at Healthcare Investor Event
22d ago
AUPH
Aurinia Pharmaceuticals Announces Executive R&D Leadership Change
PremiumCompany Announcements
Aurinia Pharmaceuticals Announces Executive R&D Leadership Change
2M ago
8K
AUPH
Aurinia Pharmaceuticals Launches Share Buyback Plan
PremiumCompany Announcements
Aurinia Pharmaceuticals Launches Share Buyback Plan
2M ago
AUPH
Aurinia Pharmaceuticals Engages Investors at March Conferences
PremiumCompany Announcements
Aurinia Pharmaceuticals Engages Investors at March Conferences
2M ago
AUPH
H.C. Wainwright cuts Aurinia target, says 28% selloff overdone
PremiumThe Fly
H.C. Wainwright cuts Aurinia target, says 28% selloff overdone
2M ago
AUPH
Aurinia Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Aurinia Pharmaceuticals call volume above normal and directionally bullish
2M ago
AUPH
New Corporate Activity and Growth Risk for Aurinia Pharmaceuticals – What’s the Latest?
PremiumMarket News
New Corporate Activity and Growth Risk for Aurinia Pharmaceuticals – What’s the Latest?
3M ago
AUPH
Aurinia Pharmaceuticals Announces Strategic Review Outcomes and Buyback Program
PremiumCompany AnnouncementsAurinia Pharmaceuticals Announces Strategic Review Outcomes and Buyback Program
3M ago
8K
AUPH
Aurinia Pharmaceuticals sees 2024 revenue $200M-$220M, consensus $217.87M
PremiumThe Fly
Aurinia Pharmaceuticals sees 2024 revenue $200M-$220M, consensus $217.87M
3M ago
AUPH
Aurinia Pharmaceuticals reports Q4 EPS (19c), consensus (16c)
PremiumThe Fly
Aurinia Pharmaceuticals reports Q4 EPS (19c), consensus (16c)
3M ago
AUPH
AUPH Earnings this Week: How Will it Perform?
PremiumPre-Earnings
AUPH Earnings this Week: How Will it Perform?
3M ago
AUPH
Aurinia Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Aurinia Pharmaceuticals call volume above normal and directionally bullish
3M ago
AUPH
Aurinia Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Aurinia Pharmaceuticals call volume above normal and directionally bullish
4M ago
AUPH
Aurinia Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Aurinia Pharmaceuticals call volume above normal and directionally bullish
4M ago
AUPH
Aurinia Pharmaceuticals sees FY24 net product revenue $200M-$220M
PremiumThe FlyAurinia Pharmaceuticals sees FY24 net product revenue $200M-$220M
4M ago
AUPH
Aurinia Pharmaceuticals sees FY23 revenue about $176M, consensus $174.71M
PremiumThe Fly
Aurinia Pharmaceuticals sees FY23 revenue about $176M, consensus $174.71M
4M ago
AUPH
Aurinia Pharmaceuticals sees Q4 revenue about $45M, consensus $44.2M
PremiumThe Fly
Aurinia Pharmaceuticals sees Q4 revenue about $45M, consensus $44.2M
4M ago
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >